Cancers | Free Full-Text | Prognosticators for Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Therapy and Pancreatectomy
A Review of Recent Real-World Evidence Data in Metastatic Pancreatic Cancer
Five-year survival rates among PDAC patients with and without DM and... | Download Scientific Diagram
Pancreatic cancer: a glimmer of hope - Nagendram - 2023 - Trends in Urology & Men's Health - Wiley Online Library
The impact of adjuvant therapy on outcome in UICC stage I pancreatic cancer - Guenther - 2022 - International Journal of Cancer - Wiley Online Library
Clinical features and prognostic impact of asymptomatic pancreatic cancer | Scientific Reports
![PDF] Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 study. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/8faa1d8f68b65770edd2aeca36796df9f4345753/6-Figure2-1.png "PDF] Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 study. | Semantic Scholar")
PDF] Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 study. | Semantic Scholar
JCM | Free Full-Text | C-Reactive Protein and Neutrophil/Lymphocytes Ratio: Prognostic Indicator for Doubling Overall Survival Prediction in Pancreatic Cancer Patients
Overall survival in patients with pancreatic cancer according to the... | Download Scientific Diagram
Perception versus reality: A National Cohort Analysis of the surgery‐first approach for resectable pancreatic cancer - Bergquist - 2021 - Cancer Medicine - Wiley Online Library
Frontiers | Prognostic Factors and Effect of Adjuvant Chemoradiation Following Chemotherapy in Resected Pancreatic Cancer Patients With Lymph Node Metastasis or R1 Resection
Frontiers | Circulating Cell-Free Tumor DNA in Advanced Pancreatic Adenocarcinoma Identifies Patients With Worse Overall Survival
Survival of pancreatic cancer patients is negatively correlated with age at diagnosis: a population-based retrospective study | Scientific Reports
The actual 5-year survivors of pancreatic ductal adenocarcinoma based on real-world data | Scientific Reports
Impact of Borderline Resectability in Pancreatic Head Cancer on Patient Survival: Biology Matters According to the New International Consensus Criteria | Annals of Surgical Oncology
Cancers | Free Full-Text | Comparing Survival after Resection of Pancreatic Cancer with and without Pancreatic Cysts: Nationwide Registry-Based Study
Pancreatic adenocarcinomas with mature blood vessels have better overall survival | Scientific Reports
Effect of Perioperative CEA and CA24-2 on Prognosis of Early Resectable Pancreatic Ductal Adenocarcinoma
Surveillance for Pancreatic Cancer in High-Risk Individuals Leads to Improved Outcomes: A Propensity Score-Matched Analysis
Surveillance for Pancreatic Cancer in High-Risk Individuals Leads to Improved Outcomes: A Propensity Score-Matched Analysis - ScienceDirect
Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial - The Lancet Oncology
Nationwide trends in incidence, treatment and survival of pancreatic ductal adenocarcinoma - ScienceDirect
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine | NEJM
Survival and Prognostic Factors in Pancreatic and Ampullary Cancer | Anticancer Research
Stratified survival of resected and overall pancreatic cancer patients in Europe and the USA in the early twenty-first century: a large, international population-based study | BMC Medicine | Full Text
Neoadjuvant chemotherapy or upfront surgery in localized pancreatic cancer: a contemporary analysis | Scientific Reports
